Relationship Between Drug Resistance Characteristics and Biofilm Formation in Klebsiella Pneumoniae Strains

References

• Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 2019;25(12):1409–1423. doi:10.2174/1381612825999190619130216
   PubMed Web of Science ®Google Scholar
• Sarshar M, Behzadi P, Ambrosi C, et al. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics. 2020;9(7):58. doi:10.3390/antibiotics9070397
   Google Scholar
• Ahmadi Z, Noormohammadi Z, Ranjbar R, et al. Prevalence of Tetracycline Resistance Genes tet (A, B, C, 39) in Klebsiella pneumoniae Isolated from Tehran, Iran. Iranian J Med Microbiol. 2022;16(2):141–147. doi:10.30699/ijmm.16.2.141
   Google Scholar
• Cusumano JA, Caffrey AR, Daffinee KE, et al. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2019;95(4):114877. doi:10.1016/j.diagmicrobio.2019.114877
   PubMed Web of Science ®Google Scholar
• Khan F, Pham DTN, Oloketuyi SF, et al. Antibiotics Application Strategies to Control Biofilm Formation in Pathogenic Bacteria. Curr Pharm Biotechnol. 2020;21(4):270–286. doi:10.2174/1389201020666191112155905
   PubMed Web of Science ®Google Scholar
• Piperaki ET, Syrogiannopoulos GA, Tzouvelekis LS, et al. Klebsiella pneumoniae: virulence, Biofilm and Antimicrobial Resistance. Pediatr Infect Dis J. 2017;36(10):1002–1005. doi:10.1097/INF.0000000000001675
   PubMed Web of Science ®Google Scholar
• Surgers L, Boyd A, Girard PM, et al. Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae. Int J Med Microbiol. 2019;309(1):13–18. doi:10.1016/j.ijmm.2018.10.008
   PubMed Web of Science ®Google Scholar
• Bellich B, Lagatolla C, Tossi A, et al. Influence of Bacterial Biofilm Polysaccharide Structure on Interactions with Antimicrobial Peptides: a Study on Klebsiella pneumoniae. Int J Mol Sci. 2018;19(6):989. doi:10.3390/ijms19061685
   PubMed Web of Science ®Google Scholar
• Salvia T, Dolma KG, Dhakal OP, et al. Phenotypic Detection of ESBL, AmpC, MBL, and Their Co-occurrence among MDR Enterobacteriaceae Isolates. J Lab Physicians. 2022;14(3):329–335. doi:10.1055/s-0042-1744239
   PubMedGoogle Scholar
• Rizvi M, Sami H, Azam M, et al. Reliability of carbapenem inactivation method (CIM) and modified carbapenem inactivation method (mCIM) for detection of OXA-48-like and NDM-1. Indian J Med Microbiol. 2021;39(4):451–456. doi:10.1016/j.ijmmb.2021.07.004
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang T, Chen L, et al. Virulence Factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol. 2021;12:642484. doi:10.3389/fmicb.2021.642484
   PubMed Web of Science ®Google Scholar
• Zhan L, Wang S, Guo Y, et al. Outbreak by Hypermucoviscous Klebsiella pneumoniae ST11 Isolates with Carbapenem Resistance in a Tertiary Hospital in China. Front Cell Infect Microbiol. 2017;7:182. doi:10.3389/fcimb.2017.00182
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang S, Fang R, et al. Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016. Infect Drug Resist. 2020;13:931–940. doi:10.2147/IDR.S243032
   PubMed Web of Science ®Google Scholar
• Dallenne C, Da Costa A, Decre D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495. doi:10.1093/jac/dkp498
   PubMed Web of Science ®Google Scholar
• Briñas L, Moreno MA, Zarazaga M, et al. Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob Agents Chemother. 2003;47(6):2056–2058. doi:10.1128/AAC.47.6.2056-2058.2003
   PubMed Web of Science ®Google Scholar
• Ferreira RL, Da Silva BCM, Rezende GS, et al. High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and beta-Lactamase Encoding Genes in a Brazilian Intensive Care Unit. Front Microbiol. 2018;9:3198. doi:10.3389/fmicb.2018.03198
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhou M, Zou M, et al. Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China. Eur J Clin Microbiol Infect Dis. 2016;35(3):387–396. doi:10.1007/s10096-015-2551-2
   PubMed Web of Science ®Google Scholar
• Fu L, Huang M, Zhang X, et al. Frequency of virulence factors in high biofilm formation bla(KPC-2) producing Klebsiella pneumoniae strains from hospitals. Microb Pathog. 2018;116:168–172. doi:10.1016/j.micpath.2018.01.030
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Dakic I, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179. doi:10.1016/s0167-7012(00)
   PubMed Web of Science ®Google Scholar
• Khonsari MS, Behzadi P, Foroohi F. The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 2021;28. doi:10.1016/j.mgene.2021.100881
   Web of Science ®Google Scholar
• Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3). doi:10.1128/CMR.00001-19
   PubMed Web of Science ®Google Scholar
• Yang X, Wai-Chi Chan E, Zhang R, et al. A conjugative plasmid that augments virulence in Klebsiella pneumoniae. Nat Microbiol. 2019;4(12):2039–2043. doi:10.1038/s41564-019-0566-7
   PubMed Web of Science ®Google Scholar
• Caneiras C, Lito L, Melo-Cristino J, et al. Community- and Hospital-Acquired Klebsiella pneumoniae Urinary Tract Infections in Portugal: virulence and Antibiotic Resistance. Microorganisms. 2019;7(5):138. doi:10.3390/microorganisms7050138
   PubMed Web of Science ®Google Scholar
• Shah RK, Ni ZH, Sun XY, et al. The Determination and Correlation of Various Virulence Genes, ESBL, Serum Bactericidal Effect and Biofilm Formation of Clinical Isolated Classical Klebsiella pneumoniae and Hypervirulent Klebsiella pneumoniae from Respiratory Tract Infected Patients. Pol J Microbiol. 2017;66(4):501–508. doi:10.5604/01.3001.0010.7042
   PubMed Web of Science ®Google Scholar
• Su SC, Siu LK, Ma L, et al. Community-acquired liver abscess caused by serotype K1 Klebsiella pneumoniae with CTX-M-15-type extended-spectrum beta-lactamase. Antimicrob Agents Chemother. 2008;52(2):804–805. doi:10.1128/AAC.01269-07
   PubMed Web of Science ®Google Scholar
• Derakhshan S, Najar Peerayeh S, Bakhshi B. Association Between Presence of Virulence Genes and Antibiotic Resistance in Clinical Klebsiella Pneumoniae Isolates. Lab Med. 2016;47(4):306–311. doi:10.1093/labmed/lmw030
   PubMed Web of Science ®Google Scholar
• Lev AI, Astashkin EI, Kislichkina AA, et al. Comparative analysis of Klebsiella pneumoniae strains isolated in 2012-2016 that differ by antibiotic resistance genes and virulence genes profiles. Pathog Glob Health. 2018;112(3):142–151. doi:10.1080/20477724.2018.1460949
   PubMed Web of Science ®Google Scholar
• Walker KA, Miller VL. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr Opin Microbiol. 2020;54:95–102. doi:10.1016/j.mib.2020.01.006
   PubMed Web of Science ®Google Scholar
• Shen P, Berglund B, Chen Y, et al. Hypervirulence Markers Among Non-ST11 Strains of Carbapenem- and Multidrug-Resistant Klebsiella pneumoniae Isolated From Patients With Bloodstream Infections. Front Microbiol. 2020;11:1199. doi:10.3389/fmicb.2020.01199
   PubMed Web of Science ®Google Scholar
• Dong N, Yang X, Chan EW, et al. Klebsiella species: taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022;79:103998. doi:10.1016/j.ebiom.2022.103998
   PubMed Web of Science ®Google Scholar
• Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes? Virulence. 2017;8(7):1111–1123. doi:10.1080/21505594.2017.1317412
   PubMed Web of Science ®Google Scholar
• Chew KL, Lin RTP. Klebsiella pneumoniae in Singapore: hypervirulent Infections and the Carbapenemase Threat. Front Cell Infect Microbiol. 2017;7:515. doi:10.3389/fcimb.2017.00515
   PubMed Web of Science ®Google Scholar
• Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi:10.1128/MMBR.00078-15
   PubMed Web of Science ®Google Scholar
• Hsieh PF, Lin TL, Lee CZ, et al. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis. 2008;197(12):1717–1727. doi:10.1086/588383
   PubMed Web of Science ®Google Scholar
• Compain F, Babosan A, Brisse S, et al. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J Clin Microbiol. 2014;52(12):4377–4380. doi:10.1128/JCM.02316-14
   PubMed Web of Science ®Google Scholar
• Jung SW, Chae HJ, Park YJ, et al. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol Infect. 2013;141(2):334–340. doi:10.1017/S0950268812000933
   PubMed Web of Science ®Google Scholar
• Kim D, Park BY, Choi MH, et al. Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection. J Antimicrob Chemother. 2019;74(1):190–199. doi:10.1093/jac/dky397
   PubMed Web of Science ®Google Scholar
• Lin ZW, Zheng JX, Bai B, et al. Characteristics of Hypervirulent Klebsiella pneumoniae: does Low Expression of rmpA Contribute to the Absence of Hypervirulence? Front Microbiol. 2020;11:436. doi:10.3389/fmicb.2020.00436
   PubMed Web of Science ®Google Scholar
• Mbelle NM, Feldman C, Sekyere JO, et al. Pathogenomics and Evolutionary Epidemiology of Multi-Drug Resistant Clinical Klebsiella pneumoniae Isolated from Pretoria, South Africa. Sci Rep. 2020;10(1):1232. doi:10.1038/s41598-020-58012-8
   PubMed Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52–59. doi:10.1093/jac/dki166
   PubMed Web of Science ®Google Scholar
• Xiaoyu Q, Qi L. Mechanism of carbapenem-resistant drugs in Klebsiella pneumoniae. J Clin Pediatrics. 2015;33(10):907–911.
   Google Scholar
• Li XU, Bei LI. Research progress on the formation mechanism of Klebsiella pneumoniae biofilm[J]. Chine J Pathogen Biol. 2016;11(11):1056–1059. doi:10.13350/j.cjpb.161123
   Google Scholar
• Duo Y, Dongyuan M, Songxue W. Relationship analysis between Klebsiella pneumoniae biofilm and bacterial resistance. Chine J Hospital Infectol. 2013;23(12):2785–2786+2851.
   Google Scholar
• Bao J, Xie L, Ma Y, et al. Proteomic and Transcriptomic Analyses Indicate Reduced Biofilm-Forming Abilities in Cefiderocol-Resistant Klebsiella pneumoniae. Front Microbiol. 2021;12:778190. doi:10.3389/fmicb.2021.778190
   PubMed Web of Science ®Google Scholar
• Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107–118. doi:10.4161/viru.22718
   PubMed Web of Science ®Google Scholar